Your browser doesn't support javascript.
loading
Resistance mechanisms to inhibitors of p53-MDM2 interactions in cancer therapy: can we overcome them?
Haronikova, Lucia; Bonczek, Ondrej; Zatloukalova, Pavlina; Kokas-Zavadil, Filip; Kucerikova, Martina; Coates, Philip J; Fahraeus, Robin; Vojtesek, Borivoj.
Afiliação
  • Haronikova L; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic. lucia.haronikova@mou.cz.
  • Bonczek O; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
  • Zatloukalova P; Department of Medical Biosciences, Umea University, 901 87, Umea, Vasterbotten, Sweden.
  • Kokas-Zavadil F; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
  • Kucerikova M; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
  • Coates PJ; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
  • Fahraeus R; National Centre for Biomolecular Research, Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
  • Vojtesek B; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53, Brno, Czech Republic.
Cell Mol Biol Lett ; 26(1): 53, 2021 Dec 15.
Article em En | MEDLINE | ID: mdl-34911439

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Farmacorresistência Bacteriana / Proteínas Proto-Oncogênicas c-mdm2 / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Farmacorresistência Bacteriana / Proteínas Proto-Oncogênicas c-mdm2 / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article